Follow the LIN share price and the full management transaction log of the company, a listed equity based in Australia. Shares trade on AU AU, under the authority of ASX. Operating in the Chemicals sector, LIN has logged 4 reports. Market capitalisation: €234.6bn. The latest transaction was disclosed on 13 May 2026 (Cease Substantial Holding). Among the most active insiders: 2. Changes in relevant interests. All data is free.
Analysts rate LIN Buy (bullish), based on 25 analysts. Average price target: A$541.61.
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
4 of 4 declarations